Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medline Inc. Class A Common Stock (MDLN) vs Mercadolibre Inc (MELI) Price & Performance

Medline Inc. Class A Common StockTrade
Mercadolibre IncTrade

Price performance (Past 24H)

Key statistics

Medline Inc. Class A Common Stock vs Mercadolibre Inc — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Mercadolibre Inc trades at $1,860.68 (market cap $94.94B). The key difference: Mercadolibre Inc is far larger — about 3.1× Medline Inc. Class A Common Stock's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Mercadolibre Inc for 117 Days on average.

MDLNMELI
Market Cap
$31.10B$94.94B
Volume
4,471,639428,337
Sector
HealthConsumer Cyclical
52-Week High
$49.99$2.36K
52-Week Low
$31.64$1.55K
Typical Hold Time
0 Days117 Days
Enterprise Value
$41.07B$102.59B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medline Inc. Class A Common Stock

No Aura AI signal available yet.

Mercadolibre Inc

MercadoLibre (MELI) trades at $1,856.66, down slightly by 0.07% on the day, with a bullish technical signal from moving averages and strong institutional support. The company reported $28.89 billion in revenue for 2025, with net income of $2.00 billion, though profit margins have softened from 9.19% in 2024 to 6.91%. Recent news highlights expansion in Brazil, including one-hour delivery and pharmacy growth, while the fintech segment's credit portfolio surged 75% to $16.4 billion in Q2 2026.

The stock presents a growth opportunity with robust revenue expansion and dominant market position in Latin American e-commerce and fintech, but faces risks from macroeconomic pressures in key markets like Argentina and elevated valuation multiples. Analyst consensus is strongly bullish with a $2,170 price target, suggesting potential upside, though investors should weigh margin compression against ecosystem strength.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDLN
100% Buy0% Sell
Avg holding period · 0 Days
MELI
22% Buy78% Sell
Avg holding period · 117 Days

Top news

Latest headlines on both assets

About Medline Inc. Class A Common Stock

Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.

Read more on MDLN →

About Mercadolibre Inc

MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Read more on MELI →